• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • New Development of FDA Regulations on Complex Generic Drugs PharmaSources/Zhulikou431
    June 03, 2021
    Since the promulgation of the Hatch-Waxman Act in 1984, in order to promote drug competition and improve public drug availability, FDA has formulated a number of policies aimed at accelerating the marketing of generic drugs.
  • Rentschler Expands Complex Antibodies Production in Germany contractpharma
    July 01, 2021
    ​Rentschler Biopharma is in the process of expanding its 2,000-liter bioreactor production capacity at its site in Germany.
  • SEA Vision Launches HarleNir contractpharma
    November 27, 2018
    Based on its Harlequin blister control system, HarleNIR is a new generation of blister inspection technology that goes beyond visible inspection to provide a chemical analysis

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service